Currently, people need to undergo different screening methods for each type of cancer. This process can be invasive, emotionally stressful, and expensive. Because patients find testing to be stressful and costly, they are not testing early enough making their cancer more difficult to treat.
PFM is developing a single blood test that can detect multiple cancer types at earlier stages. This service is coupled with deep learning technology that enables higher accuracy in early stage detection. This AI-powered technology identifies specific compounds in the blood to detect cancer-associated patterns. PFM aims to increase the accessibility and success rate of earlier cancer detection, resulting in immediate treatment worldwide.
Nobuhiro Andrew Kawai (Andy)
Healthcare Service Business Unit
In this Moon Talk!, we hear from two entrepreneurs in the emerging GX industry as they share their key learnings.
Audio content can easily lose its intended effect when narrated by someone other than the other. VOOX aims to change that.